EMD Serono forms partnership to discover MS treatments

03/19/2009 | Mass High Tech (Boston)

EMD Serono, a biopharmaceutical unit of Merck KGaA, signed a two-year agreement with the National Multiple Sclerosis Society to speed up research and development of treatments for multiple sclerosis. Under the deal, Merck will invest as much as $19 million in the joint venture and EMD will work with Fast Forward, the society's nonprofit subsidiary.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Medical Director - Physician
Willamette Valley Community Health
Salem, OR